INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
45 hedge funds and large institutions have $4.23M invested in Infinity Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Holders
45
Holding in Top 10
–
Calls
$25K
Puts
$4K
Top Buyers
| 1 | +$252K | |
| 2 | +$63.1K | |
| 3 | +$25.8K | |
| 4 |
EWM
Evercore Wealth Management
New York
|
+$15.2K |
| 5 |
WIM
Wittenberg Investment Management
Carlisle,
Massachusetts
|
+$12K |
Top Sellers
| 1 | -$62.9K | |
| 2 | -$28.8K | |
| 3 | -$25.5K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11.1K |